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Humans have evolved over millions of years
and adapted to a solar day of approximately
12 hr of light and 12 hr of dark, latitude and
season permitting. Our ability to artificially
light the night began about 250,000 years ago
when we discovered how to use ﬁre. Candles
were introduced about 5,000 years ago, and
gas street lighting was possible beginning in
the mid-1700s. However, only in the last
120 years has environmental illumination
begun to change on a pervasive scale for the
masses of people through the introduction of
electric lighting. One of the deﬁning features
of the built environment in the modern world
is this artiﬁcial lighting. Electricity has made it
possible to light the inside of large buildings
and light the night for work, recreation, and
security. The beneﬁts of this lighting are obvi-
ous and enormous. It has become apparent,
however, that although of obvious beneﬁt, it
may not be completely innocuous. Light,
including artiﬁcial light, can be potent in regu-
lating human physiology and behavior and can
therefore alter human physiology when in-
appropriately timed. One example of potential
light-induced disruption is the effect of light
on circadian organization, including the pro-
duction of several hormone rhythms. Changes
in light–dark exposure shift the timing of the
circadian system such that internal rhythms
can become desynchronized from both the
external environment and internally with each
other, impairing our ability to sleep and wake
at the appropriate times and compromising
metabolic processes. Light can also have direct
acute effects on neuroendocrine systems, for
example, in suppressing melatonin synthesis or
elevating cortisol production that may have
untoward long-term consequences.
There is limited but thus far generally con-
sistent evidence in support of the hypothesis
that altered lighting can play a role in breast
cancer causation (Blask et al. 2005a; Hansen
2001; Stevens 1987, 2006), and there is grow-
ing interest in a lighting and/or sleep connec-
tion to other conditions such as prostate cancer
(Kubo et al. 2006; Stevens et al. 1992), obesity
(Spiegel et al. 2004), diabetes (Spiegel et al.
2005), and depression (Srinivasan et al. 2006).
It may not be entirely coincidental that the
dramatic increases in risk of breast and prostate
cancers, and of obesity and early onset diabetes
have mirrored the dramatic changes in the
amount and pattern of artiﬁcial light generated
during the night and day in modern societies
over recent decades. The science underlying
these hypotheses has a solid base and is
currently moving forward rapidly.
For these reasons, the National Institute
of Environmental Health Sciences (NIEHS)
on 14–15 September 2006 convened a work-
shop of a diverse group of scientists to con-
sider how best to conduct research on
possible connections between lighting and
health. The potential for circadian disruption,
particularly light exposures at night, to con-
tribute to the etiology of cancer or other dis-
eases has become an urgent question in part
because a large and increasing segment of the
population of industrialized nations is work-
ing nonday shifts (Rajaratnam and Arendt
2001). It is also important because the popu-
lation in general has been reducing its expo-
sure to dark over recent decades as reflected
in a decrease in the average duration of sleep
(National Sleep Foundation 2005).
Deﬁnitions
“Diurnal rhythms” denote recurring daily
24-hr rhythms in physiology, behavior, or
metabolism under entrainment conditions
but not necessarily under constant, non-
entrainment conditions. “Entrainment” is the
synchronization of a rhythm by a repetitive
signal (e.g., the light–dark cycle). “Circadian
rhythms” (e.g., melatonin production) denote
those endogenous, near 24-hr physiologic,
metabolic, or behavioral rhythms that persist
under constant nonentrainment conditions
(e.g., constant darkness) and are presumably
driven by the molecular clockwork mecha-
nism in the suprachiasmatic nucleus (SCN)
and peripheral tissues (Dunlap et al. 2004). 
Background
Circadian rhythms—master and peripheral
clocks. The hypothalamic SCN is the master
circadian pacemaker in mammals, driving
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Light, including artiﬁcial light, has a range of effects on human physiology and behavior and can
therefore alter human physiology when inappropriately timed. One example of potential light-
induced disruption is the effect of light on circadian organization, including the production of sev-
eral hormone rhythms. Changes in light–dark exposure (e.g., by nonday occupation or transmeridian
travel) shift the timing of the circadian system such that internal rhythms can become desynchro-
nized from both the external environment and internally with each other, impairing our ability to
sleep and wake at the appropriate times and compromising physiologic and metabolic processes.
Light can also have direct acute effects on neuroendocrine systems, for example, in suppressing mela-
tonin synthesis or elevating cortisol production that may have untoward long-term consequences.
For these reasons, the National Institute of Environmental Health Sciences convened a workshop of
a diverse group of scientists to consider how best to conduct research on possible connections
between lighting and health. According to the participants in the workshop, there are three broad
areas of research effort that need to be addressed. First are the basic biophysical and molecular
genetic mechanisms for phototransduction for circadian, neuroendocrine, and neurobehavioral regu-
lation. Second are the possible physiologic consequences of disrupting these circadian regulatory
processes such as on hormone production, particularly melatonin, and normal and neoplastic tissue
growth dynamics. Third are effects of light-induced physiologic disruption on disease occurrence and
prognosis, and how prevention and treatment could be improved by application of this knowledge.
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pineal gland. Environ Health Perspect 115:1357–1362 (2007). doi:10.1289/ehp.10200 available via
http://dx.doi.org/ [Online 14 June 2007]circadian rhythms in behavior, physiology,
endocrinology, and metabolism (Ko and
Takahashi 2006; Moore and Leak 2001). The
core genetic apparatus of the clock mecha-
nism is being rapidly revealed and thus far
appears to be based on a small number of
genes (Fu and Lee 2003; Hastings et al.
2003). Lesions of the SCN abolish these
rhythms. Such lesion studies cannot discount
the possibility that the SCN is merely serving
as a relay point to or from a “true” pace-
maker. However, transplantation of SCN
donor tissue derived from circadian period
mutants into SCN-lesioned wild-type hosts
resulted in a transfer of period from donor to
host, thereby proving the SCN to be a true
master pacemaker (Ralph et al. 1990).
In the early 1990s, peripheral circadian
oscillators were not thought to be prevalent,
existing only in the eyes of frogs and mammals
(Cahill et al. 1991; Tosini and Menaker 1996).
In the late 1990s, however, the use of biolumi-
nescent reporter proteins expressed under the
control of clock gene promoters revealed that
circadian oscillators resided in many peripheral
tissues of vertebrates and invertebrates
(Balsalobre et al. 1998; Plautz et al. 1997).
This concept is depicted in Figure 1. These
oscillators could be entrained and phase shifted
by biologically relevant stimuli such as light.
Interestingly, treatments resulting in large
abrupt phase shifts caused peripheral tissues to
become transiently desychronized as a result of
differential rates of phase shifting to the stimu-
lus (Yamazaki et al. 2000). 
Recently, the effect of chronic jet lag on
aged mice was shown to have dramatic conse-
quences on mortality (Davidson et al. 2006).
Only 47% of aged mice forced to phase
advance 6 hr once per week survived the
experiment compared with an 83% survival
rate in an unshifted age-matched control
group. Aged mice subjected to weekly 6-hr
phase delays showed an intermediate survival
(68%). These profound effects of phase shift-
ing were not observed in younger mice. The
mechanism by which chronic jet lag hastens
death in aged mice remains to be determined.
The authors of the study speculate that the
internal desynchrony of oscillators likely to
result from a rotating light schedule may have
dire consequences that may be exacerbated by
age (Davidson et al. 2006). If this reasonable
hypothesis is proven true, then the effects of
exposure to uncontolled environmental light-
ing may have a detrimental impact on health,
where the ultimate outcome may be much
more serious than previously believed.
Experimental simulation of jet lag in mice
has also been shown to increase growth of
Glasgow osteosarcoma (Filipski et al. 2004).
Disruption of circadian physiology by muta-
tion or ablation of specific clock genes has
also been tested for effects on cancer growth.
Mutation in the Period 2 (Per2) gene was
shown to increase susceptibility to radiation-
induced lymphoma (Fu et al. 2002). Gauger
and Sancar (2005), however, showed that
abolishment of circadian rhythmicity alone
was not sufﬁcient to affect tumor growth by
ﬁnding no increase in lymphoma after radia-
tion exposure to cryptochrome knockout
mice. In addition, exposure of rats bearing
human breast cancer xenografts (or murine
tumors) to light in night has been shown to
stimulate tumor growth, metabolism, and sig-
nal transduction activity (Blask et al. 2005a,
2005b) (Figure 2).
Phototransduction for the circadian sys-
tem. Empiric evidence from the past three
decades has conﬁrmed that, relatively separate
from vision and visual reﬂexes, light incident
on the retina can be a potent biological,
behavioral, and therapeutic stimulus in
humans (Commission Internationale de
L’Eclairage 2007). Recently, there has been a
paradigm shift in the understanding of photo-
reception for circadian, neuroendocrine, and
neurobehavioral responses in humans. In
2001, two action spectra for melatonin sup-
pression in humans showed that mono-
chromatic blue light was most potent for
melatonin suppression in humans (Brainard
et al. 2001; Thapan et al. 2001). Altogether,
the elucidation of eight separate action spectra
in rodents, monkeys, and humans showed that
the short wavelength blue portion of the visi-
ble spectrum between 459–484 nm is the
most potent wavelength region for a range of
biological and behavioral responses in these
species [for review, see Brainard and Haniﬁn
(2005)]. Other studies have confirmed that
Stevens et al.
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Figure 2. A schematic representation of the cancer response to the effects of an intact nocturnal, circa-
dian melatonin signal (A) under 12-hr:12-hr light/dark conditions and (B) under conditions in which the
melatonin signal is disrupted by ocular exposure to bright polychromatic light at night.
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Figure 1. The suprachiasmatic nuclei (SCN) and other circadian oscillators drive a broad range of circa-
dian rhythms. These rhythms, in turn, can feedback on the oscillators. In addition to this feedback regula-
tion, the oscillators are entrained by photic and nonphotic environmental time cues. 
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sympathetic indicators)shorter wavelength monochromatic light is
more potent than equal photon densities of
longer wavelength light for evoking circadian
phase shifts, suppressing melatonin, and
enhancing alertness in humans (Cajochen et al.
2005; Lockley et al. 2003, 2006; Revell et al.
2006). Together, the full analytic action spec-
tra along with the selected wavelength testing
indicate that a novel photoreceptor system, dis-
tinct from the visual rods and cones, is primar-
ily involved in circadian, neuroendocrine, and
neurobehavioral responses mediated by the
eyes of humans and other mammals. 
Studies employing both animal and
human models are rapidly clarifying the neuro-
anatomy and neurophysiology of this photo-
sensory system. A recently discovered
photopigment, melanopsin, has been localized
in the retinas of both rodents and humans
(Provencio et al. 1998, 2000). More specifi-
cally, melanopsin is found in a subtype of
intrinsically photoreceptive retinal ganglion
cells (ipRGCs) (Berson et al. 2002; Hattar
et al. 2002). These light-sensitive retinal gan-
glion cells extend an expansive arbor of den-
drites that seems to form a “photoreceptive
net” and project to the SCN via the retino-
hypothalamic tract for circadian phototrans-
duction (Gooley et al. 2001; Provencio et al.
2002). Although the light detection for circa-
dian, neuroendocrine, and neurobehavioral
regulation seems to be mediated principally by
ipRGCs, studies with melanopsin knockout
mice have shown that the classic rod and cone
visual photoreceptors nevertheless appear to
have some role in modulating these responses
(Hattar et al. 2002; Panda et al. 2003).
Workshop
The NIEHS sponsored a workshop on 14 and
15 September 2006 charged with producing “a
prioritized set of research recommendations
that will guide future NIH [National Institutes
of Health] funding agendas as well as a publi-
cation that will assist the research community
in their efforts.” Participants at the workshop
represented a diverse array of scientiﬁc exper-
tise from molecular genetics of the clock mech-
anism in cyanobacteria to molecular biology of
phototransduction in the mammalian retina,
the effects of light on human physiology, circa-
dian rhythm sleep disorders, physiologic effects
of sleep on hunger, experimental carcinogene-
sis, epidemiology of disease occurrence, and
application of circadian principles to treatment
of cancer patients. Although some participants
had worked together in the past, many were
new to the topics of health research and archi-
tectural lighting. The meeting was highly
unusual in the breadth of its cross-discipline
content. Yet given the complexity of the light-
ing, circadian rhythms, and health subject mat-
ters, and the importance of the diseases that
might be involved, this broad expertise was
required for engendering productive inter-
action among participants to ensure that the
mandate of the workshop was met.
The most studied environmental exposure
that can disrupt circadian rhythms is light.
However, other factors are emerging that have
this potential and include the timing of meals
(Filipski et al. 2005; Mendoza 2007), stress
(Funk and Amir 1999), and alcohol (Allen
et al. 2005). It is only recently being investi-
gated how these can interact with light expo-
sure. To the extent that early-life exposures,
even in utero (Hilakivi-Clarke and de Assis
2006), can affect lifetime risk of cancer,
maternal exposure to altered lighting, and
these other potential circadian disruptors
need to be investigated.
Recommendations
The short-term goal of the workshop was to
lay the foundation for the development of a
better understanding of the extent to which
changes in the lighted environment that come
with industrialization contribute to the etiol-
ogy and affect the risk of human disorders
such as breast cancer, other cancers, and other
chronic diseases. Another workshop objective
was to foster an understanding of the role that
light plays in conjunction with other environ-
mental and endogenous factors (e.g., fatty
acids) that may affect cancer development and
growth. Of primary concern are the altered
light exposures during the night and day as
they impact circadian and diurnal physiologic
rhythms. It is also a priority to understand the
biological mechanisms connecting disruption
of circadian and diurnal processes with disease
etiology. Importantly, characteristics of the
individual that might modify the effect of
environmental lighting on health need to be
elucidated. The long-term goal is, of course, to
use the newly acquired knowledge of the
mechanisms and consequences of circadian
disruption from altered lighting to develop
interventional strategies and technologies for
reducing health risks from, for example, non-
day shift work in which a large and increasing
segment of the population is employed.
There are three broad areas of research
effort that need to be addressed. First are the
basic biophysical and molecular genetic ques-
tions of how the retina transduces the photic
input to a neuronal signal to the circadian sys-
tem and other brain neural substrates that
mediate non-image-forming effects of light, and
once received, how these signals are transduced
to other cells and tissues of the body. It has
become clear that photic sensing for the circa-
dian, neuroendocrine, and neurobehavioral
effects of light is not by vision per se but via a
novel photoreceptor system located in the gan-
glion cell layer of the retina. Fundamentally, the
basic biophysics of nonvisual phototransduc-
tion needs to be understood, that is, its
absolute, spectral, spatial, and temporal
response characteristics. Among the interesting
questions identified: Do the absolute and
spectral sensitivities change throughout the
solar day? Does a single spectral sensitivity
characterize the photic input to every light-
responsive, nonvisual system of the brain?
How does prior light exposure affect light sen-
sitivity (Hebert et al. 2002)? And, signifi-
cantly, how can basic knowledge be used to
develop lighting regimens or sources that miti-
gate the adverse consequences of altered light
exposure, for example to reduce circadian mis-
alignment in shift workers?
Second are questions of physiologic con-
sequences of disrupting the normal function-
ing and temporal synchronization of the
circadian and other neurobehavioral systems:
How are hormone production and release
affected both acutely and chronically? How
are the timing and synchronization of meta-
bolic processes affected? How does altering
clock gene function affect cell cycle check-
point genes and genes of apoptosis in suscep-
tible tissue such as breast and prostate? These
questions can be addressed in laboratory
studies in experimental models and in clinical
trials with human subjects with end points
such as circulating hormone level alterations
over the course of a 24-hr period.
Figure 3 shows an integrative model for a
light-induced effect on breast cancer etiology
[adapted from Stevens (2005)]. Speciﬁc genetic
polymorphisms may act at several points along
this proposed causal pathway. There has been
one study published based on this scheme that
reported increased risk of breast cancer in
Role of lighting in disease
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Figure 3. Model for mechanisms for a light-induced
effect on breast cancer [adapted from Stevens
(2005)]. Possible targets for research on genetic
polymorphisms that might affect the process are
indicated.
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Third are questions of disease occurrence,
prevention, and treatment, which must be
addressed with epidemiology and clinical tri-
als. For example, can risks for speciﬁc diseases
such as breast cancer be quantiﬁed in terms of
light exposure, and can this information be
used to mitigate exposure and lower risk?
Twenty-five attendees of the NIEHS
workshop identiﬁed ﬁve core areas of priority
research effort. These are all closely inter-
twined with one another and directed toward
the larger goal of understanding how light and
dark influence human health in the modern
world. Each core area requires expertise from
different but overlapping scientiﬁc disciplines,
and cross-disciplinary communication among
researchers in the ﬁve areas is paramount.
Priority Research Foci
In the next section we discuss the ﬁve priority
core research topics identiﬁed by the workshop
participants that should be addressed in order
for progress to advance on the important envi-
ronmental issue of lighting and health. There
are dramatic changes in the health profile of
populations as societies industrialize and begin
increasing their use of electric lighting. At the
same time, risks of certain cancers rise (e.g.,
breast and prostate), as does the prevalence of
obesity and early-onset diabetes. Reasons for
these increases are only partly understood, and
all of them are likely to be multifactorial.
Altered environmental lighting during the day
and night may play a large role in some dis-
eases, an ancillary role in others, and perhaps
no role in others. A crucial aspect of research in
this area is accurate quantiﬁcation of the light
exposure (Bierman et al. 2005; Bullough et al.
2006; Figueiro et al. 2006).
To effectively address the theory that light-
at-night increases cancer risk or risk of other
diseases, a wide array of study designs is
required (Roenneberg and Lucas 2002). Both
epidemiologic and experimental approaches
need to be conducted on each of the many
aspects of the idea, but alone both the epidemi-
ology (Poole 2002) and the experimental mod-
els (Anisimov 2005) have limitations in causal
assessment for human risk. In particular, no
one set of epidemiologic approaches is ade-
quate nor could they prove a cause and effect
exists. For example, a sufficient number of
high-quality epidemiologic findings of
increased risk of breast cancer in shift-working
women may lead to the conclusion that shift
workers are indeed at higher risk, yet they can-
not prove that light-at-night (LAN), or more
generally, circadian disruption, is the reason
(Stevens 2006). First, nonday shift workers are
different in many ways from day workers, thus
presenting the potential for confounding; and
second, even if the cause is shift work itself,
there are other aspects of working nonday
shifts apart from circadian disruption. For a
conclusion of causality, the LAN theory must
be tested in many different settings with very
different speciﬁc predictions, and consistency
seen across these studies (Hill 1965). 
We do not believe, however, that research
on potential interventions should be postponed
until the risk has been unequivocally quantiﬁed;
the two research directions should both pro-
ceed. In addition, for useful intervention strate-
gies to be identiﬁed there needs to be a detailed
understanding of the biological mechanism
provided from experimental studies in animal
models, cellular systems, and in humans.
Speciﬁc Research Directions
and Needs
As with any research agenda, a complex biol-
ogy must be reduced to speciﬁcs. This is a per-
ilous process. As Einstein was reputed to have
said “Make things as simple as possible, but
not simpler.” Circadian biology is not simple
nor are the mechanisms by which lighting
could disrupt the circadian rhythms or other
elements of human physiology. Yet there is a
simple truth that certain diseases become
much more common as industrialization
occurs in societies. And so, we have accepted
the challenge to make concrete research sug-
gestions while at the same time risking over
simpliﬁcation and/or unintentionally ignoring
important aspects of the problem.
Biophysical and physiologic mechanisms of
ocular phototransduction for the circadian,
neuroendocrine, and neurobehavioral effects
of light.
• What are the basic mechanisms of circadian,
neuroendocrine, and neurobehavioral photo-
transduction in humans and in animal models?
• What are the parameters of the photic input
that affect these processes?
• What are the patterns of light and dark expo-
sures that people experience in everyday life
and how can they be parametrically studied
in humans and with experimental models?
Molecular and physiologic mechanisms
underlying circadian and diurnal rhythmic-
ity—hierarchical and nonheirarchical mecha-
nisms for synchronicity of master and
peripheral clocks.
• How does the master circadian clock in the
SCN communicate with the peripheral oscil-
lators in response to ocular light exposure?
• Given that there are multiple circadian clocks
in the body, how does disruption of their
timing by light affect disease?
• How does the relationship between internal
clocks and environmental light affect disease?
Testing specific disease-association
hypotheses for disruption of circadian and
diurnal rhythms.
• At present, diseases of primary interest
are breast cancer, prostate cancer, obesity,
diabetes, and depression. Is their onset,
maintenance, or recurrence a result of dis-
rupted circadian or diurnal rhythms?
• Given the state of the science, what epidemi-
ologic studies are needed to deﬁne the light
exposure/disease relationships?
• What practical/feasible markers of disrup-
tion (that can be used in large numbers of
humans) need to be validated in the clinic/
laboratory for use in epidemiologic studies?
• Given the emerging evidence that “clock”
genes control the expression of a signifi-
cant amount of the genome, which poly-
morphisms in them can be evaluated for
disease associations? A resequencing effort
for their population variability should be
undertaken.
•What gene–environment interactions
between clock polymorphisms and expo-
sures (such as shift work) are important in
disease susceptibility?
• Does accelerated tumor growth due to light
exposure at night have the same increased
wavelength sensitivity as the other circadian,
neuroendocrine, and neurobehavioral
responses? 
• What intensities of polychromatic light
exposures contribute to tumorigenesis and
tumor growth?
• What is the balance of ipRGC, rod, and
cone cell mediation of the effect of light on
tumorigenesis and tumor growth?
Role of endogenous melatonin in mediat-
ing light-induced–associated disease and
development of exogenous melatonin therapy
to prevent or alleviate light-induced disease.
Although the human circadian system
encompasses a vast array of physiologic
responses, the hormone melatonin deserves
particular attention for a possible connection
to cancer for two reasons (Blask et al. 2005a,
2005b; Figure 2). First, melatonin is the bio-
chemical signal for darkness, and its timing,
duration, and amplitude respond to seasonal
changes in photoperiod, specifically night-
length. It is therefore the primary vehicle by
which light information is translated into a
biological signal and, as such, is a primary
candidate for assessing the effect of light on
individuals. A great deal of information is
available on melatonin parameters under a
variety of lighting conditions. Its strong signal
and availability either as melatonin or its
metabolites in blood, saliva, and urine make it
a good marker for a range of studies. Second,
melatonin has well-established oncostatic
properties in experimental in vitro and in vivo
models that can be studied in their own right
as a potential mediator in disease develop-
ment or through administration of synthetic
melatonin as an adjuvant therapy for light- or
melatonin-associated diseases. In addition to
melatonin’s direct oncostatic properties, the
endogenous melatonin signal may thwart
Stevens et al.
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mechanism’s involving its ability to enhance
immune activity and mitigate against stress-
induced immune suppression (Maestroni
1993; Sephton and Spiegel 2003).
• What defining aspects of light (intensity,
spectrum, spatial pattern, duration, and
timing) exposure at night incur the highest
and the least cancer risk in humans via cir-
cadian/melatonin disruption?
• What are the relative short- and long-term
contributions of light in night-induced sup-
pression of the nocturnal circadian mela-
tonin signal versus its circadian phase
disruption to the cancer initiation, growth,
progression, and invasion/metastasis? 
• What is the “balance” between circadian
melatonin signal strength (i.e., phase,
amplitude, duration), melatonin receptor
expression/sensitivity, and dietary tumor
stimulatory/inhibitory (i.e., linoleic acid/
omega-3 fatty acids) factors in cancer-suscep-
tible target tissues that determines whether
these tissues will be at more or less risk for
developing cancer in response to circadian
disruption of melatonin by light at night?
• What are the interactions between the noctur-
nal circadian melatonin signal and its disrup-
tion by light at night, melatonin receptors,
and cancer clock genes that may be involved
in regulating oncogenesis and/or tumor
suppressor genes? 
• What does light in night-induced immune
suppression contribute to cancer develop-
ment and/or growth via melatonin suppres-
sion and/or through nonmelatonin, stress-
related mechanisms? 
• Because the timing and amount of melatonin
are regulated by light, and that it is both a
chronobiotic and anticancer agent, how does
disruption of melatonin by light, and use of
pharmacologic melatonin supplementation as
a chronobiotic and anticancer agent impact
the risk and progression of cancer?
• What improvements in melatonin measure-
ments can be made so that melatonin will
be a more useful biomarker in epidemio-
logic studies?
• What are the optimal standards for measur-
ing melatonin?
Development of interventions and treat-
ments designed to reduce the impact of envi-
ronmental lighting on disease.
• Can disruption of circadian, neuroendocrine,
and neurobehavioral processes be ameliorated
to treat or prevent disease?
• How can exposure to light and darkness be
optimized to reduce the risk of cancer and
other diseases, for example in shift workers?
• What are the other candidate interventions
(e.g., melatonin supplementation, dietary
modiﬁcations, therapeutic drugs)?
• What are the relative contributions of and
interactions between the circadian and
homeostatic processes of sleep/wake regula-
tion, and light at night-induced circadian
disruption in disorders of energy metabo-
lism as related to cancer, obesity and type II
diabetes? What circadian-based interven-
tions can be implemented to prevent or
treat such disorders?
Summary
One of the defining characteristics of life in
the modern world is the altered patterns of
light and dark in the built environment made
possible by use of electric power. A rapidly
growing and very exciting body of basic sci-
ence is uncovering the mechanisms for photo-
transduction in the retina for environmental
control of circadian and other neurobehavioral
responses and the makeup and functioning of
the clock physiology that exert genetic control
of the endogenous rhythms. It is beginning to
be realized by the larger scientiﬁc community
that maintenance of these circadian rhythms is
important to health and well-being. Our chal-
lenge for the future is to integrate the basic sci-
ence with studies in experimental animals and
clinical and epidemiologic research to advance
our understanding of the impact of circadian
disruption from lighting, and what then can
be done to minimize or eliminate the adverse
consequences for human health.
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